Cargando…
A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer
Anakinra, the recombinant form of IL-1 receptor antagonist (IL-1Ra), has been approved for clinical use in the treatment of rheumatoid arthritis as the drug Kineret™, but it must be administered daily by subcutaneous injection. Gene transfer may offer a more effective means of delivery. In this stud...
Autores principales: | Gouze, Jean-Noel, Gouze, Elvire, Palmer, Glyn D, Liew, Victor S, Pascher, Arnulf, Betz, Oliver B, Thornhill, Thomas S, Evans, Christopher H, Grodzinsky, Alan J, Ghivizzani, Steven C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC193732/ https://www.ncbi.nlm.nih.gov/pubmed/12932294 |
Ejemplares similares
-
scAAV-Mediated Gene Transfer of Interleukin 1-Receptor Antagonist to Synovium and Articular Cartilage in Large Mammalian Joints
por: Watson, Rachael S., et al.
Publicado: (2012) -
Gene therapy for cartilage healing
por: Ghivizzani, SC, et al.
Publicado: (2001) -
The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics
por: Evans, Christopher H, et al.
Publicado: (2005) -
Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1β
por: Gouze, Jean-Noël, et al.
Publicado: (2006) -
In vitro and in vivo gene delivery using a lentiviral vector
por: Gouze-Decaris, E, et al.
Publicado: (2001)